INSPECT was designed to serve as a tool to address the problem of prescription drug abuse and diversion in Indiana. By compiling controlled substance information into an online database (PMP Webcenter) INSPECT performs two critical functions:
INSPECT does not seek to limit the ability of doctors to perform their jobs effectively, nor does it intend to violate individual privacy or patient rights. Various security measures have been put in place to prevent abuse and ensure the confidentiality of patient medical records and other privileged information.
The Indiana General Assembly passed legislation in the mid-1990s that required the collection of controlled substance data through the Central Repository for Controlled Substances Data.
At its inception, Indiana’s Prescription Drug Monitoring program required licensed pharmacies in Indiana to report on dispensed schedule II controlled substances. In early 2004, grant funding and an act of the legislature helped create INSPECT in its present form, expanding reporting requirements to include schedule II through V controlled substances.
INSPECT continues to be partially funded through the Harold Rogers grant program, which provides similar funding in other states. Additional funding for INSPECT is provided at the state level, derived from a percentage of controlled substance licensing fees.
All data collection and maintenance activities for INSPECT are handled in-house. The data repository is accessible only to registered users and available only through a secure Web site maintained by program staff.